NVSNovartis AG

ADRCNew York Stock Exchange (XNYS)·USD

Identity

Security key: 19437
Ticker: NVS
Type: ADRC — American Depository Receipt Common
Exchange: New York Stock Exchange(XNYS)
Venue group: NYSE
Operating MIC: XNYS
Market: stocks
Locale: us
Currency: USD
Listed: 1996-11-07
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: NVS

Detail

Enriched 2026-08-14 20:47

Market cap: $289,516,884,428.8
Shares outstanding (class): 2,034,819,509
Shares outstanding (weighted): 1,900,714,840
SIC: —
Employees: 75,267
Location: —
Homepage: https://www.novartis.com
Description: Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.

Market cap and share counts drift.

Funds holding this security

79 funds · 83 positions · $3.37B reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD PRIMECAP FUND VANGUARD CHESTER FUNDS	—	$794.33M	1.10%	5,200,175 NS	FIGI
Dodge & Cox Stock Fund Dodge & Cox Funds	—	$777.12M	0.68%	5,087,508 NS	FIGI
Loomis Sayles Growth Fund LOOMIS SAYLES FUNDS II	—	$228.54M	1.43%	1,496,178 NS	FIGI
VANGUARD CAPITAL OPPORTUNITY FUND VANGUARD HORIZON FUNDS	—	$185.01M	0.75%	1,211,220 NS	FIGI
Franklin Mutual Global Discovery Fund Franklin Mutual Series Funds	—	$182.10M	2.03%	1,192,174 NS	FIGI
Janus Henderson Global Life Sciences Fund JANUS INVESTMENT FUND	—	$148.41M	2.86%	971,619 NS	FIGI
VanEck Pharmaceutical ETF VanEck ETF Trust	PPH	$138.39M	10.76%	905,997 NS	FIGI
Franklin Mutual Shares Fund Franklin Mutual Series Funds	—	$128.13M	1.92%	838,792 NS	FIGI
VANGUARD PRIMECAP CORE FUND VANGUARD FENWAY FUNDS	—	$102.31M	0.76%	669,790 NS	FIGI
GQG PARTNERS US SELECT QUALITY EQUITY FUND ADVISORS' INNER CIRCLE III	—	$101.94M	3.52%	667,383 NS	FIGI
Franklin Mutual Beacon Fund Franklin Mutual Series Funds	—	$84.33M	2.49%	552,063 NS	FIGI
Franklin Mutual Quest Fund Franklin Mutual Series Funds	—	$47.37M	1.80%	310,110 NS	FIGI
Loomis Sayles Growth Portfolio Brighthouse Funds Trust I	—	$38.35M	1.41%	251,032 NS	FIGI
Franklin Mutual Shares VIP Fund Franklin Templeton Variable Insurance Produ…	—	$35.08M	1.92%	229,673 NS	FIGI
First Trust Value Line Dividend Index Fund First Trust Exchange-Traded Fund	FVD	$34.97M	0.43%	228,945 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERNVS
FIGI_COMPOSITEBBG000LYF3S8
FIGI_SHARE_CLASSBBG001SF5LW6
CIK0001114448
ISINUS66987V1098
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Novartis is a global pharmaceutical company, so it falls under healthcare and pharmaceuticals.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.